Wednesday 14 November 2018
Home      All news      Contact us     
cnbc.com - 2 month ago

JP Morgan says buy Stryker shares because of its new medical technology products

J.P. Morgan reiterates its overweight rating for the Stryker shares, predicting the medical technology company will report earnings above expectations next year.

Related news

Latest News
Hashtags:   

Morgan

 | 

Stryker

 | 

shares

 | 

because

 | 

medical

 | 

technology

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources